"Fluoxetine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
Concept/Terms
Fluoxetine- Fluoxetine
- N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
- Fluoxetin
Below are MeSH descriptors whose meaning is more general than "Fluoxetine".
Below are MeSH descriptors whose meaning is more specific than "Fluoxetine".
This graph shows the total number of publications written about "Fluoxetine" by people in Harvard Catalyst Profiles by year, and whether "Fluoxetine" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 11 | 1 | 12 |
| 1992 | 8 | 4 | 12 |
| 1993 | 5 | 8 | 13 |
| 1994 | 9 | 6 | 15 |
| 1995 | 9 | 2 | 11 |
| 1996 | 12 | 7 | 19 |
| 1997 | 9 | 10 | 19 |
| 1998 | 13 | 4 | 17 |
| 1999 | 10 | 2 | 12 |
| 2000 | 8 | 2 | 10 |
| 2001 | 6 | 5 | 11 |
| 2002 | 16 | 5 | 21 |
| 2003 | 10 | 3 | 13 |
| 2004 | 21 | 6 | 27 |
| 2005 | 11 | 4 | 15 |
| 2006 | 12 | 4 | 16 |
| 2007 | 11 | 6 | 17 |
| 2008 | 8 | 6 | 14 |
| 2009 | 10 | 4 | 14 |
| 2010 | 10 | 9 | 19 |
| 2011 | 2 | 4 | 6 |
| 2012 | 9 | 2 | 11 |
| 2013 | 3 | 2 | 5 |
| 2014 | 3 | 1 | 4 |
| 2015 | 7 | 4 | 11 |
| 2016 | 6 | 9 | 15 |
| 2017 | 4 | 0 | 4 |
| 2018 | 6 | 1 | 7 |
| 2019 | 5 | 0 | 5 |
| 2020 | 1 | 2 | 3 |
| 2021 | 0 | 1 | 1 |
Below are the most recent publications written about "Fluoxetine" by people in Profiles.
-
A Sequential Multiple Assignment Randomized Trial (SMART) study of medication and CBT sequencing in the treatment of pediatric anxiety disorders. BMC Psychiatry. 2021 06 30; 21(1):323.
-
The Effect of Lactobacillus casei Consumption in Improvement of Obsessive-Compulsive Disorder: an Animal Study. Probiotics Antimicrob Proteins. 2020 12; 12(4):1409-1419.
-
Stress-mediated hyperactivity and anhedonia resistant to diazepam and fluoxetine in drosophila. Stress. 2021 01; 24(1):96-106.
-
A placebo prognostic index (PI) as a moderator of outcomes in the treatment of adolescent depression: Could it inform risk-stratification in treatment with cognitive-behavioral therapy, fluoxetine, or their combination? Psychother Res. 2021 01; 31(1):5-18.
-
Changes in Gut Microbiota by Chronic Stress Impair the Efficacy of Fluoxetine. Cell Rep. 2020 03 17; 30(11):3682-3690.e6.
-
Implementation research for public sector mental health care scale-up (SMART-DAPPER): a sequential multiple, assignment randomized trial (SMART) of non-specialist-delivered psychotherapy and/or medication for major depressive disorder and posttraumatic stress disorder (DAPPER) integrated with outpatient care clinics at a county hospital in Kenya. BMC Psychiatry. 2019 12 28; 19(1):424.
-
Latent Profiles of Cognitive and Interpersonal Risk Factors for Adolescent Depression and Implications for Personalized Treatment. J Abnorm Child Psychol. 2019 12; 47(12):1957-1967.
-
MAMBO: Measuring ambulation, motor, and behavioral outcomes with post-stroke fluoxetine in Tanzania: Protocol of a phase II clinical trial. J Neurol Sci. 2020 Jan 15; 408:116563.
-
Combining Fluoxetine and rTMS in Poststroke Motor Recovery: A Placebo-Controlled Double-Blind Randomized Phase 2 Clinical Trial. Neurorehabil Neural Repair. 2019 08; 33(8):643-655.
-
Fluoxetine Induces Morphological Rearrangements of Serotonergic Fibers in the Hippocampus. ACS Chem Neurosci. 2019 07 17; 10(7):3218-3224.